HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Doris Feineis Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

1/2023Dioncophyllidine E: The first configurationally semi-stable, 7,3'-coupled naphthyldihydroisoquinoline alkaloid, from Ancistrocladus abbreviatus, with antiausterity activity against PANC-1 human pancreatic cancer cells.
1/2021Ancistrobrevidines A-C and related naphthylisoquinoline alkaloids with cytotoxic activities against HeLa and pancreatic cancer cells, from the liana Ancistrocladus abbreviatus.
11/2018Ancistrobrevines E-J and related naphthylisoquinoline alkaloids from the West African liana Ancistrocladus abbreviatus with inhibitory activities against Plasmodium falciparum and PANC-1 human pancreatic cancer cells.
10/2018Ancistroyafungines A-D, 5,8'- and 5,1'-coupled naphthylisoquinoline alkaloids from a Congolese Ancistrocladus species, with antiausterity activities against human PANC-1 pancreatic cancer cells.
1/2018Michellamines A6 and A7, and further mono- and dimeric naphthylisoquinoline alkaloids from a Congolese Ancistrocladus liana and their antiausterity activities against pancreatic cancer cells.
10/2017Jozilebomines A and B, Naphthylisoquinoline Dimers from the Congolese Liana Ancistrocladus ileboensis, with Antiausterity Activities against the PANC-1 Human Pancreatic Cancer Cell Line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Doris Feineis Research Topics

Disease

9Neoplasms (Cancer)
12/2023 - 12/2016
6Leukemia
12/2023 - 12/2016
6Pancreatic Neoplasms (Pancreatic Cancer)
01/2023 - 10/2017
4Parkinson Disease (Parkinson's Disease)
11/2017 - 05/2002
3Multiple Myeloma
08/2023 - 01/2017
1Hematologic Neoplasms (Hematological Malignancy)
08/2023
1African Trypanosomiasis (Nagana)
01/2021
1Malaria
01/2021
1Parasitic Diseases (Parasitic Disease)
07/2020
1Carcinoma (Carcinomatosis)
11/2019
1Fibrosarcoma
11/2019
1Starvation
10/2018
1Squamous Cell Carcinoma of Head and Neck
07/2018
1Neuroblastoma
11/2017
1Pheochromocytoma
07/2006

Drug/Important Bio-Agent (IBA)

11AlkaloidsIBA
01/2023 - 01/2017
41- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
11/2017 - 05/2002
3NeurotoxinsIBA
07/2006 - 05/2002
2dioncophylline AIBA
12/2023 - 01/2017
2jozimine A2IBA
11/2019 - 10/2017
21- trichloromethyl- 1,2,3,4- tetrahydro- beta- carbolineIBA
11/2017 - 07/2006
2Carbolines (Beta-Carbolines)IBA
07/2006 - 05/2002
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
09/2023
117- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA
09/2023
1geldanamycinIBA
09/2023
1ancistrocladinium AIBA
08/2023
1Proteasome InhibitorsIBA
08/2023
1imidocarb dipropionateIBA
07/2020
1Oxygen (Dioxygen)IBA
10/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2018
1PolyphenolsIBA
07/2018
1Fluorouracil (Carac)FDA LinkGeneric
01/2018
1E 10 (E-10)IBA
01/2018
1ancistrobenomine BIBA
09/2017
1P 11 (P-11)IBA
01/2017
1LignansIBA
01/2017
1Melphalan (Alkeran)FDA LinkGeneric
01/2017
1ancistectorine DIBA
12/2016
1trichloroacetaldehydeIBA
07/2006
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
07/2006

Therapy/Procedure

2Therapeutics
09/2023 - 07/2018